» Articles » PMID: 34852226

CD19-CAR T cells Undergo Exhaustion DNA Methylation Programming in Patients with Acute Lymphoblastic Leukemia

Abstract

CD19-CAR T cell therapy has evolved into the standard of care for relapsed/refractory B cell acute lymphoblastic leukemia (ALL); however, limited persistence of the CAR T cells enables tumor relapse for many patients. To gain a deeper understanding of the molecular characteristics associated with CAR T cell differentiation, we performed longitudinal genome-wide DNA methylation profiling of CD8 CD19-CAR T cells post-infusion in ALL patients. We report that CAR T cells undergo a rapid and broad erasure of repressive DNA methylation reprograms at effector-associated genes. The CAR T cell post-infusion changes are further characterized by repression of genes (e.g., TCF7 and LEF1) associated with memory potential and a DNA methylation signature (e.g., demethylation at CX3CR1, BATF, and TOX) demarcating a transition toward exhaustion-progenitor T cells. Thus, CD19-CAR T cells undergo exhaustion-associated DNA methylation programming, indicating that efforts to prevent this process may be an attractive approach to improve CAR T cell efficacy.

Citing Articles

Characterization of Rationally Designed CRISPR/Cas9-Based DNA Methyltransferases with Distinct Methyltransferase and Gene Silencing Activities in Human Cell Lines and Primary Human T Cells.

Guerra-Resendez R, Lydon S, Ma A, Bedford G, Reed D, Kim S ACS Synth Biol. 2025; 14(2):384-397.

PMID: 39898483 PMC: 11854388. DOI: 10.1021/acssynbio.4c00569.


Dual-targeting CAR T cells for B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma.

de Oliveira Canedo G, Roddie C, Amrolia P Blood Adv. 2024; 9(4):704-721.

PMID: 39631066 PMC: 11869864. DOI: 10.1182/bloodadvances.2024013586.


Transcriptional rewiring in CD8 T cells: implications for CAR-T cell therapy against solid tumours.

Srinivasan S, Armitage J, Nilsson J, Waithman J Front Immunol. 2024; 15:1412731.

PMID: 39399500 PMC: 11466849. DOI: 10.3389/fimmu.2024.1412731.


T cell exhaustion methylation signature drives differential immune responses in glioblastoma.

Chen F, Qian W, Chen Z, Qian J, Luo C Discov Oncol. 2024; 15(1):530.

PMID: 39377985 PMC: 11461406. DOI: 10.1007/s12672-024-01412-3.


IL-4 drives exhaustion of CD8 CART cells.

Stewart C, Siegler E, Sakemura R, Cox M, Huynh T, Kimball B Nat Commun. 2024; 15(1):7921.

PMID: 39266501 PMC: 11393358. DOI: 10.1038/s41467-024-51978-3.


References
1.
Deng Q, Han G, Puebla-Osorio N, Ma M, Strati P, Chasen B . Characteristics of anti-CD19 CAR T cell infusion products associated with efficacy and toxicity in patients with large B cell lymphomas. Nat Med. 2020; 26(12):1878-1887. PMC: 8446909. DOI: 10.1038/s41591-020-1061-7. View

2.
Zebley C, Gottschalk S, Youngblood B . Rewriting History: Epigenetic Reprogramming of CD8 T Cell Differentiation to Enhance Immunotherapy. Trends Immunol. 2020; 41(8):665-675. PMC: 7395868. DOI: 10.1016/j.it.2020.06.008. View

3.
Alfei F, Kanev K, Hofmann M, Wu M, Ghoneim H, Roelli P . TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection. Nature. 2019; 571(7764):265-269. DOI: 10.1038/s41586-019-1326-9. View

4.
Flynn J, Gorry P . Stem memory T cells (TSCM)-their role in cancer and HIV immunotherapies. Clin Transl Immunology. 2014; 3(7):e20. PMC: 4232066. DOI: 10.1038/cti.2014.16. View

5.
Abdelsamed H, Moustaki A, Fan Y, Dogra P, Ghoneim H, Zebley C . Human memory CD8 T cell effector potential is epigenetically preserved during in vivo homeostasis. J Exp Med. 2017; 214(6):1593-1606. PMC: 5461005. DOI: 10.1084/jem.20161760. View